Ignite Creation Date:
2025-12-24 @ 12:41 PM
Ignite Modification Date:
2026-03-20 @ 2:25 AM
Study NCT ID:
NCT06739161
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-12-18
First Post:
2024-12-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sintilimab in Combination with Chemotherapy ± Local Treatment for Om-G/GEJ
Sponsor:
Jiangsu Cancer Institute & Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
SCIR for G/GEJ
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None